These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35165707)

  • 1. Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study.
    Chen Y; Fu W; Zheng Y; Yang J; Liu Y; Qi Z; Wu M; Fan Z; Yin K; Chen Y; Gao W; Ding Z; Dong J; Li Q; Zhang S; Hu L
    Eur Heart J; 2022 Oct; 43(37):3556-3574. PubMed ID: 35165707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 Pathway.
    Chen Y; Hong J; Zhong H; Zhao Y; Li J; Shen W; Luo X; Shi H; Hu L; Liu J; Gao W
    Circ Res; 2023 Apr; 132(9):e134-e150. PubMed ID: 36999436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asebogenin suppresses thrombus formation via inhibition of Syk phosphorylation.
    Li L; Xu X; Lv K; Zheng G; Wang H; Chen S; Huang L; Liu Y; Zhang Y; Tang Z; Zhang L; Wang J; Qiao J; Li H; Wang X; Yao G; Fang C
    Br J Pharmacol; 2023 Feb; 180(3):287-307. PubMed ID: 36166754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
    Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Kv1.3 Channels in Platelet Functions and Thrombus Formation.
    Fan C; Yang X; Wang WW; Wang J; Li W; Guo M; Huang S; Wang Z; Liu K
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2360-2375. PubMed ID: 32787516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
    Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk.
    Xue Y; Zhang L; Zhang L; Sun W; Fang Z; Leng Y; Li M; Ren X; Zhang R; Zhang Y; Chen L; Wang H
    Phytomedicine; 2022 Sep; 104():154271. PubMed ID: 35777120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
    Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
    Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
    Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
    Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets Express Activated P2Y
    Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z
    Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
    Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
    Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
    Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
    Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
    Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.
    Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment.
    Tullemans BME; Veninga A; Fernandez DI; Aarts MJB; Eble JA; van der Meijden PEJ; Heemskerk JWM; Kuijpers MJE
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release.
    Xin G; Wei Z; Ji C; Zheng H; Gu J; Ma L; Huang W; Morris-Natschke SL; Yeh JL; Zhang R; Qin C; Wen L; Xing Z; Cao Y; Xia Q; Li K; Niu H; Lee KH; Huang W
    Free Radic Biol Med; 2017 Jul; 108():247-257. PubMed ID: 28188927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
    Shih TL; Lin KH; Chen RJ; Chen TY; Kao WT; Liu JW; Wang HH; Peng HY; Sun YY; Lu WJ
    J Cell Mol Med; 2021 Oct; 25(19):9434-9446. PubMed ID: 34448532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.